Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study

Fig. 1

Empirical antimicrobial therapy adaptation in the case of a negative (upper panel) or positive (lower panel) betaLACTA® test (BLT). Whatever the beta-lactam empirically administered to patients, cefotaxime was chosen to pursue antimicrobial therapy once the BLT results were negative. Conversely, carbapenems were chosen if the BLT was positive. The definitive antimicrobial therapy was prescribed after the results of antibiotic susceptibility tests, confirming the BLT-adapted beta-lactam antibiotic or using another molecule if necessary. Amox. amoxicillin, Clav. clavulanate, Pip. piperacillin, Taz. tazobactam

Back to article page
\